Kotowsky, Nirali
20  Ergebnisse:
Personensuche X
?
1

POSTER: MM-508 Belantamab Mafodotin for Relapsed or Refract..:

Hultcrantz, Malin ; Kleinman, David ; Vij, Ravi...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S222 , 2023
 
?
3

P-272 Belantamab mafodotin for relapsed/refractory multiple..:

Hultcrantz, Malin ; Kleinman, David ; Vij, Ravi...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S185-S186 , 2023
 
?
4

MM-508 Belantamab Mafodotin for Relapsed or Refractory Mult..:

Hultcrantz, Malin ; Kleinman, David ; Vij, Ravi...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S504 , 2023
 
?
5

P-238 A real-world observational study of belantamab mafodo..:

Cavo, Michele ; Delforge, Michel ; Dimopoulos, Meletios...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S166-S167 , 2023
 
?
6

Impact of Generalized Pustular Psoriasis from the Perspecti..:

Reisner, Dale V. ; Johnsson, Frida Dunger ; Kotowsky, Nirali...
American Journal of Clinical Dermatology.  23 (2022)  S1 - p. 65-71 , 2022
 
?
 
?
9

25031 Greater disease burden associated with palmoplantar p..:

Lebwohl, Mark ; Kotowsky, Nirali ; Medeiros, Rose A....
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB4 , 2021
 
?
10

Clinical characteristics and health‐care resource utilizati..:

Okubo, Yukari ; Kotowsky, Nirali ; Gao, Ran..
The Journal of Dermatology.  48 (2021)  11 - p. 1675-1687 , 2021
 
?
11

26588 Patient-reported outcomes from a large, North America..:

Strober, Bruce ; Kotowsky, Nirali ; Medeiros, Rose A....
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB108 , 2021
 
?
12

Healthcare Resource Utilization and Baseline Characteristic..:

Sobell, Jeffrey M. ; Gao, Ran ; Golembesky, Amanda K....
Journal of Psoriasis and Psoriatic Arthritis.  6 (2021)  3 - p. 143-150 , 2021
 
?
13

Clinical Characteristics and HealthCare Resource Utilizatio..:

Crowley, Jeffrey ; Golembesky, Amanda K. ; Kotowsky, Nirali...
Journal of Psoriasis and Psoriatic Arthritis.  6 (2021)  3 - p. 151-158 , 2021
 
?
 
1-15